These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 31621996)
1. G-Quadruplex-Binding Small Molecule Induces Synthetic Lethality in Breast Cancer Cells by Inhibiting c-MYC and BCL2 Expression. Paul R; Das T; Debnath M; Chauhan A; Dash J Chembiochem; 2020 Apr; 21(7):963-970. PubMed ID: 31621996 [TBL] [Abstract][Full Text] [Related]
2. Cell penetrating thiazole peptides inhibit c-MYC expression via site-specific targeting of c-MYC G-quadruplex. Dutta D; Debnath M; Müller D; Paul R; Das T; Bessi I; Schwalbe H; Dash J Nucleic Acids Res; 2018 Jun; 46(11):5355-5365. PubMed ID: 29762718 [TBL] [Abstract][Full Text] [Related]
3. Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia. Hu MH; Yu BY; Wang X; Jin G Bioorg Chem; 2020 Nov; 104():104264. PubMed ID: 32920366 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction. Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689 [TBL] [Abstract][Full Text] [Related]
5. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex. Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069 [TBL] [Abstract][Full Text] [Related]
6. Syntheses and Evaluation of New Bisacridine Derivatives for Dual Binding of G-Quadruplex and i-Motif in Regulating Oncogene Kuang G; Zhang M; Kang S; Hu D; Li X; Wei Z; Gong X; An LK; Huang ZS; Shu B; Li D J Med Chem; 2020 Sep; 63(17):9136-9153. PubMed ID: 32787078 [TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex. Shan C; Yan JW; Wang YQ; Che T; Huang ZL; Chen AC; Yao PF; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS J Med Chem; 2017 Feb; 60(4):1292-1308. PubMed ID: 28128954 [TBL] [Abstract][Full Text] [Related]
8. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells. Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213 [TBL] [Abstract][Full Text] [Related]
10. Human Telomeric G-Quadruplex Selective Fluoro-Isoquinolines Induce Apoptosis in Cancer Cells. Maiti S; Saha P; Das T; Bessi I; Schwalbe H; Dash J Bioconjug Chem; 2018 Apr; 29(4):1141-1154. PubMed ID: 29433312 [TBL] [Abstract][Full Text] [Related]
11. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the Hu MH; Lin JH J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424 [TBL] [Abstract][Full Text] [Related]
12. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives. Chauhan A; Paladhi S; Debnath M; Dash J Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597 [TBL] [Abstract][Full Text] [Related]
13. Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth. Kendrick S; Muranyi A; Gokhale V; Hurley LH; Rimsza LM J Med Chem; 2017 Aug; 60(15):6587-6597. PubMed ID: 28605593 [TBL] [Abstract][Full Text] [Related]
14. New Disubstituted Quindoline Derivatives Inhibiting Burkitt's Lymphoma Cell Proliferation by Impeding c-MYC Transcription. Liu HY; Chen AC; Yin QK; Li Z; Huang SM; Du G; He JH; Zan LP; Wang SK; Xu YH; Tan JH; Ou TM; Li D; Gu LQ; Huang ZS J Med Chem; 2017 Jul; 60(13):5438-5454. PubMed ID: 28603988 [TBL] [Abstract][Full Text] [Related]
15. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression. Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961 [TBL] [Abstract][Full Text] [Related]
16. A small molecule peptidomimetic that binds to c-KIT1 G-quadruplex and exhibits antiproliferative properties in cancer cells. Chauhan A; Paladhi S; Debnath M; Mandal S; Das RN; Bhowmik S; Dash J Bioorg Med Chem; 2014 Aug; 22(16):4422-9. PubMed ID: 24961873 [TBL] [Abstract][Full Text] [Related]
17. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions. Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286 [TBL] [Abstract][Full Text] [Related]
18. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription. Hu MH; Wu TY; Huang Q; Jin G Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090 [TBL] [Abstract][Full Text] [Related]
19. Disabling c-Myc in childhood medulloblastoma and atypical teratoid/rhabdoid tumor cells by the potent G-quadruplex interactive agent S2T1-6OTD. Shalaby T; von Bueren AO; Hürlimann ML; Fiaschetti G; Castelletti D; Masayuki T; Nagasawa K; Arcaro A; Jelesarov I; Shin-ya K; Grotzer M Mol Cancer Ther; 2010 Jan; 9(1):167-79. PubMed ID: 20053783 [TBL] [Abstract][Full Text] [Related]
20. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design. Harikrishna S; Kotaru S; Pradeepkumar PI Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]